Type of Study:
Device
Study Length:
5 years
Target Age/Sex:
Male or Female over the age of 18
Benefits:
Participants will receive at no cost: Study product, study visits, and study specific procedures. Participants may also receive compensation for their time and travel.
Status: Closed
Description:
A durability study with the FDA approved Altaviva device for the treatment of overactive bladder or urge incontinence.
Privacy Policy: Participants agree to receive text messages from Rosemark Womencare Specialist Clinical Research sent from (208) 487-4999. Message frequency varies and may include text similar to the following: Appointment reminders, service or order information, etc. Message and data rates may apply. Reply STOP at any time to end or unsubscribe. For assistance, reply HELP or contact support at: (208) 557-2924
See our Privacy Policy for details on how we handle your information